## Abstract In this study, the biocompatibility of a calcium phosphate (CaP) cement incorporating poly (D,Lโlacticโ__co__โglycolic acid) (PLGA) microparticles was evaluated in a subcutaneous implantation model in rats. Shortโterm biocompatibility was assessed using pure CaP discs and CaP discs inco
Evaluation of an orthotopically implanted calcium phosphate cement containing gelatin microparticles
โ Scribed by Dennis P. Link; Juliette van den Dolder; Jeroen J. J. P. van den Beucken; Wouter Habraken; Annemieke Soede; Otto C. Boerman; Antonios G. Mikos; John A. Jansen
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 610 KB
- Volume
- 90A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
This study focused on the degradation properties of gelatin microparticles incorporated in calcium phosphate (CaP) cement and the subsequent effect of these composites on bone formation. Positively charged alkaline gelatin (type A) microparticles or negatively charged acidic gelatin (type B) microparticles were incorporated in CaP cement, which was implanted in criticalโsized cranial defect in rats and left in place for 2, 4, and 8 weeks. The degradation of the gelatin was monitored using radioiodinated microparticles. After 4 and 8 weeks of implantation, a significantly faster degradation of type A gelatin over type B gelatin was found. Light microscopic analysis of the specimens showed similar bone response concerning implants containing either type A or B gelatin microparticles. At 2 weeks of implantation, a minimal amount of bone formation was observed from the cranial bone toward the implant, while after 8 weeks of implantation an entire layer of newly formed bone was present from the cranial bone toward the implant periphery. Bone ingrowth into the implant was observed at sites of gelatin microparticle degradation, predominantly at the implant periphery. Histomorphometrical evaluation did not reveal significant differences in bone formation between CaP cement incorporated with either type A or B gelatin microparticles during implantation periods up to 8 weeks. In conclusion, this study demonstrates that gelatin type influences the degradation of gelatin microparticles incorporated in CaP cements. However, this difference in degradation and the concomitant subsequent macroporosity did not induce differences in the biological response. ยฉ 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009
๐ SIMILAR VOLUMES
## Abstract For tissue engineered bone constructs, calcium phosphate cement (CPC) has a high potential as scaffold material because of its biocompatibility and osteoconductivity. However, __in vivo__ resorption and tissue ingrowth is slow. To address these issues, microspheres can be incorporated i
## Abstract Development of macroporosity during setting would allow fast bone ingrowth and good osteointegration of the implant. The interconnected macropores could be created in calcium phosphate cements (CPCs) through the addition of an effervescent porogen mixture to the component of the cements
## Abstract This __in vivo__ study evaluated the fixation of two types of titanium implants with the use of an injectable calciumโphosphate (CaP) cement. The cement was either used to create a cement mantle (Type A implant) or as an additive to pressโfit placed titanium plasma sprayed implants (Typ
## Abstract The aim of the current study was to evaluate the effect of a calcium phosphate material equipped with poly (lacticโ__co__โglycolic acid) microspheres for pulp capping, and to measure the dentin bridge formation, when using various concentrations of transforming growth factor (TGF) ฮฒ1. P
To evaluate the soft tissue response of calcium phosphate cement (CPC), consisting of an equimolar mixture of tetracalcium phosphate (TTCP) and dicalcium phosphate anhydrous (DCPA) under conditions close to those encountered in actual surgical procedures, we implanted three types of CPC [conventiona